Veterinary Zinc Bacitracin Market

Zinc Bacitracin is a mixture of high-molecular-weight polypeptides (bacitracin A, B, C, and several minor components). Zinc Bacitracin occurs as a yellowish gray-brown to brown powder. It has characteristic odor. It is freely soluble in dilute hydrochloric acid, water, pyridine, and menthol. Bacitracin has antibacterial effect on Gram-negative bacteria, actinomycetes, and leptospirae, and strong antibacterial effect on Gram-positive bacteria. It has growth-promoting effect on chickens (including broilers), pigs, and cattle.

Veterinary Zinc Bacitracin Market contains market size and forecasts of Veterinary Zinc Bacitracin in global, including the following market information:

Global Veterinary Zinc Bacitracin Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Veterinary Zinc Bacitracin Market Sales, 2017-2022, 2023-2028, (MT)

Global top five Veterinary Zinc Bacitracin companies in 2021 (%)

The global Veterinary Zinc Bacitracin market was valued at 121.7 million in 2021 and is projected to reach US$ 172.1 million by 2028, at a CAGR of 5.1% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

10% Zinc Bacitracin Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Veterinary Zinc Bacitracin include Zoetis, Ceva Corporate, Huvepharma, Lifecome Biochemistry, Qilu Pharmaceutical, Orion Animal Nutrition, Vega Pharma and Tianjin Xinxing Veterinary Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Veterinary Zinc Bacitracin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Veterinary Zinc Bacitracin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Veterinary Zinc Bacitracin Market Segment Percentages, by Type, 2021 (%)

10% Zinc Bacitracin

15% Zinc Bacitracin

Global Veterinary Zinc Bacitracin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Veterinary Zinc Bacitracin Market Segment Percentages, by Application, 2021 (%)

Pigs

Cattle

Chicken

Others

Global Veterinary Zinc Bacitracin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Veterinary Zinc Bacitracin Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Veterinary Zinc Bacitracin revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Veterinary Zinc Bacitracin revenues share in global market, 2021 (%)

Key companies Veterinary Zinc Bacitracin sales in global market, 2017-2022 (Estimated), (MT)

Key companies Veterinary Zinc Bacitracin sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Zoetis

Ceva Corporate

Huvepharma

Lifecome Biochemistry

Qilu Pharmaceutical

Orion Animal Nutrition

Vega Pharma

Tianjin Xinxing Veterinary Pharmaceutical